Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes

Diabetologia

Volumn 60, Issue 3, 2017, Pages 518-530

  Sandler, Victoria ^a   Reisetter, Anna C ^a   Bain, James R ^b,c   Muehlbauer, Michael J ^b,c   Nodzenski, Michael ^a   Stevens, Robert D ^b,c   Ilkayeva, Olga ^b,c   Lowe, Lynn P ^a   Metzger, Boyd E ^a   Newgard, Christopher B ^b,c   Scholtens, Denise M ^a   Lowe, William L ^a   for the HAPO Study Cooperative Research Group, ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Duke University School of Medicine ^*

Author keywords

Fetal growth; Maternal BMI; Maternal insulin resistance; Maternal metabolism; Pregnancy

Indexed keywords

ACYLCARNITINE; AMINO ACID; BRANCHED CHAIN AMINO ACID; CARBOHYDRATE; CARBOXYLIC ACID; LIPID; GLUCOSE BLOOD LEVEL;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMICAL ANALYSIS; BIRTH WEIGHT; BODY MASS; CAUCASIAN; CHILDHOOD OBESITY; FEMALE; GESTATIONAL AGE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLOME; METABOLOMICS; NEWBORN; NEWBORN ASSESSMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOM FOREST; ADULT; GLUCOSE BLOOD LEVEL; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; YOUNG ADULT;

ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GESTATIONAL AGE; HUMANS; INSULIN RESISTANCE; METABOLOME; OBESITY; PREGNANCY; PREGNANCY OUTCOME; YOUNG ADULT;

EID: 85006154152     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-4182-2     Document Type: Article

References (49)

1. HAPO Study Cooperative Research Group (2010) Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study: associations with maternal body mass index. BJOG 117:575–584
2. Desert R, Canlet C, Costet N, Cordier S, Baonvallot N (2015) Impact of maternal obesity on the metabolic profiles of pregnant women and their offspring at birth. Metabolomics 11:1896–1907
3. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL (2016) Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315:2284–2291
4. Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780–786
5. Cnattingius S, Reilly M, Pawitan Y, Lichtenstein P (2004) Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am J Med Genet A 130:365–371
6. Nelson SM, Matthews P, Poston L (2010) Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Hum Reprod Update 16:255–275
7. Schellong K, Schulz S, Harder T, Plagemann A (2012) Birthweight and long-term overweight risk: systematic review and a meta-analysis including 643,902 persons from 66 studies and 26 countries globally. PLoS One 7, e47776
8. Black MH, Sacks DA, Xiang AH, Lawrence JM (2013) The relative contribution of prepregnancy overweight and obesity, gestational weight gain, and IADPSG-defined gestational diabetes mellitus to fetal overgrowth. Diabetes Care 36:56–62
9. Stuebe AM, Landon MB, Lai Y et al (2012) Maternal BMI, glucose tolerance, and adverse pregnancy outcomes. Am J Obstet Gynecol 207:62.e1–62.e7
10. Tyrrell J, Richmond RC, Palmer TM et al (2016) Genetic evidence for causal relationships between maternal obesity-related traits and birthweight. JAMA 315:1129–1140
11. Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002
12. Hayes MG, Urbanek M, Hivert MF et al (2013) Identification of HKDC1 and BACE2 as genes influencing glycemic traits during pregnancy through genome-wide association studies. Diabetes 62:3282–3291
13. Scholtens DM, Bain JR, Reisetter AC et al (2016) Metabolic networks and metabolites underlie associations between maternal glucose during pregnancy and newborn size at birth. Diabetes 65:2039–2050
14. Urbanek M, Hayes MG, Armstrong LL et al (2013) The chromosome 3q25 genomic region is associated with measures of adiposity in newborns in a multi-ethnic genome-wide association study. Hum Mol Genet 22:3583–3596
15. HAPO Study Cooperative Research Group (2002) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study. Int J Gynaecol Obstet 78:69–77
16. Radaelli T, Farrell KA, Huston-Presley L et al (2010) Estimates of insulin sensitivity using glucose and C-peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test. Diabetes Care 33:490–494
17. Scholtens DM, Muehlbauer MJ, Daya NR et al (2014) Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy. Diabetes Care 37:158–166
18. Kind T, Wohlgemuth G, Lee do Y (2009) FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 81:10,038–10,048
19. Halket JM, Przyborowska A, Stein SE, Mallard WG, Down S, Chalmers RA (1999) Deconvolution gas chromatography/mass spectrometry of urinary organic acids – potential for pattern recognition and automated identification of metabolic disorders. Rapid Commun Mass Spectrom 13:279–284
20. Nodzenski M, Muehlbauer MJ, Bain JR, Reisetter AC, Lowe WL Jr, Scholtens DM (2014) Metabomxtr: an R package for mixture-model analysis of non-targeted metabolomics data. Bioinformatics 30:3287–3288
21. Benjamini Y, Hochberg Y (2000) On the adaptive control of the false discovery rate in multiple testing with independent statistics. J Educ Behav Stat 25:60–83
22. Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M (2016) KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44:D457–D462
23. Goeman JJ, van de Geer SA, de Kort F, van Houwelingen HC (2004) A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20:93–99
24. Beisser D, Klau GW, Dandekar T, Muller T, Dittrich MT (2010) BioNet: an R-package for the functional analysis of biological networks. Bioinformatics 26:1129–1130
25. Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Muller T (2008) Identifying functional modules in protein–protein interaction networks: an integrated exact approach. Bioinformatics 24:i223–i231
26. Csardi G, Nepusz T (2006) The igraph software package for complex network research. Interjournal - Complex Systems: 1695
27. Reichardt J, Bornholdt S (2006) Statistical mechanics of community detection. Phys Rev E 74:016110
28. Breiman L (2001) Random forests. Mach Learn 45:5–32
29. Strobl C, Boulesteix AL, Kneib T, Augustin T, Zeileis A (2008) Conditional variable importance for random forests. BMC Bioinforma 9:307
30. Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311–326
31. Schooneman MG, Vaz FM, Houten SM, Soeters MR (2013) Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62:1–8
32. Huynh J, Xiong G, Bentley-Lewis R (2014) A systematic review of metabolite profiling in gestational diabetes mellitus. Diabetologia 57:2453–2464
33. Dudzik D, Zorawski M, Skotnicki M et al (2014) Metabolic fingerprint of gestational diabetes mellitus. J Proteomics 103:57–71
34. Lowe WL Jr, Karban J (2014) Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy. Diabet Med 31:254–262
35. Hajduk J, Klupczynska A, Derezinski P et al (2015) A combined metabolomic and proteomic analysis of gestational diabetes mellitus. Int J Mol Sci 16:30,034–30,045
36. Lindsay KL, Hellmuth C, Uhl O et al (2015) Longitudinal metabolomic profiling of amino acids and lipids across healthy pregnancy. PLoS One 10, e0145794
37. Luan H, Meng N, Liu P et al (2014) Pregnancy-induced metabolic phenotype variations in maternal plasma. J Proteome Res 13:1527–1536
38. Pinto J, Barros AS, Domingues MR et al (2015) Following healthy pregnancy by NMR metabolomics of plasma and correlation to urine. J Proteome Res 14:1263–1274
39. Kim JY, Park JY, Kim OY et al (2010) Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 9:4368–4375
40. Valcarcel B, Ebbels TM, Kangas AJ et al (2014) Genome metabolome integrated network analysis to uncover connections between genetic variants and complex traits: an application to obesity. J R Soc Interface 11:20130908
41. Cheng S, Rhee EP, Larson MG et al (2012) Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 125:2222–2231
42. Ho JE, Larson MG, Ghorbani A et al (2016) Metabolomic profiles of body mass index in the Framingham Heart Study reveal distinct cardiometabolic phenotypes. PLoS One 11, e0148361
43. Vidakovic AJ, Jaddoe VW, Gishti O et al (2015) Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the Generation R Study. Eur J Epidemiol 30:1175–1185
44. Haggarty P (2010) Fatty acid supply to the human fetus. Annu Rev Nutr 30:237–255
45. Tai ES, Tan ML, Stevens RD et al (2010) Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia 53:757–767
46. Catalano PM, Hauguel-De Mouzon S (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204:479–487
47. Jang C, Oh SF, Wada S et al (2016) A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med 22:421–426
48. Tremblay F, Krebs M, Dombrowski L et al (2005) Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54:2674–2684
49. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H (2006) Maternal lipid metabolism and placental lipid transfer. Horm Res 65(Suppl 3):59–64